why choose us

First received: December 19, 2022

Clinical Trial: Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Immunization

Study Type: INTERVENTIONAL


Official Title: Comparison of the Immune Response After Administration of 2 vs. 3 Doses of the FDA-approved 9-Valent HPV Vaccine Among Women 27-45 Years of Age

Brief Summary: The goal of this clinical trial is to compare a 2-dose and 3-dose series of 9vHPV vaccine among 27-45-year-old females to assess if 2 doses elicit a noninferior immune response.Participants will be randomized 1:1 to either the 2-dose group or the 3-dose group and asked to provide 4 blood samples over a period of 12 months.All 2-dose participants will be offered a 3rd dose after the final blood draw,12 months after their initial vaccination.

Read more